# 21Shares Ethereum Staking ETF: financial statements, quarterly

TETH · CBOE · CIK 1992508 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/teth.md) · [Financials](/companies/teth/financials.md) · [Filings](/companies/teth/filings.md) · [Insiders](/companies/teth/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/teth/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2025 (2024-09-30) | Q4 FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [(3.2)](/filings/0001213900-25-110784.md) | [7.6](/filings/0001013762-25-002795.md) | [(9.9)](/filings/0001213900-26-057485.md) | [6.5](/filings/0001213900-26-089297.md) | [17.0](/filings/0001213900-25-110784.md) | [(12.2) d](/filings/0001213900-26-036641.md) | [(8.0)](/filings/0001213900-26-057485.md) | [(4.1)](/filings/0001213900-26-089297.md) |

- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss

## Balance sheet

| Line item | Unit | period not labelled (2024-06-30) | Q3 FY2025 (2024-09-30) | FY2025 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001213900-24-073379.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [0.4](/filings/0001213900-24-073379.md) | [12.6](/filings/0001213900-24-096768.md) | [16.9](/filings/0001213900-26-036641.md) | [8.4](/filings/0001213900-25-042786.md) | [23.0](/filings/0001213900-25-075767.md) | [45.9](/filings/0001213900-25-110784.md) | [31.3](/filings/0001213900-26-089297.md) | [20.8](/filings/0001213900-26-057485.md) | [12.9](/filings/0001213900-26-089297.md) |
| Total liabilities | $m | [0.1](/filings/0001213900-24-073379.md) | not reported | not reported | [0.0](/filings/0001213900-25-042786.md) | [0.0](/filings/0001213900-25-075767.md) | [0.0](/filings/0001213900-25-110784.md) | not reported | [2.6](/filings/0001213900-26-057485.md) | not reported |
| Shareholders' equity | $m | [0.3](/filings/0001213900-25-110784.md) | [12.6](/filings/0001213900-25-110784.md) | [16.9](/filings/0001213900-26-089297.md) | [8.4](/filings/0001213900-26-089297.md) | [23.0](/filings/0001213900-26-089297.md) | [45.9](/filings/0001213900-25-110784.md) | [31.3](/filings/0001213900-26-089297.md) | [18.2](/filings/0001213900-26-089297.md) | [12.9](/filings/0001213900-26-089297.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 1,620,000 at 2026-08-07, from the cover of the [10-Q filed 2026-08-14](/filings/0001213900-26-089297.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.